91 related articles for article (PubMed ID: 21666562)
21. Clinical significance of ras oncogene activation in human lung cancer.
Rodenhuis S; Slebos RJ
Cancer Res; 1992 May; 52(9 Suppl):2665s-2669s. PubMed ID: 1562997
[TBL] [Abstract][Full Text] [Related]
22. [Pulmonary carcinogenesis susceptibility-associated single-nucleotide polymorphisms in K-ras intron 2 affect the binding of factor Gata-6 but not gene expression].
Timofeeva OA; Gorshkova EV; Levashova ZB; Kobzev VF; Filipenko ML; Kaledin VI; Merkulova TI
Mol Biol (Mosk); 2002; 36(5):817-24. PubMed ID: 12391845
[TBL] [Abstract][Full Text] [Related]
23. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas.
Sugio K; Kishimoto Y; Virmani AK; Hung JY; Gazdar AF
Cancer Res; 1994 Nov; 54(22):5811-5. PubMed ID: 7954406
[TBL] [Abstract][Full Text] [Related]
24. A novel molecular staging protocol for non-small cell lung cancer.
Miyake M; Adachi M; Huang C; Higashiyama M; Kodama K; Taki T
Oncogene; 1999 Apr; 18(14):2397-404. PubMed ID: 10327061
[TBL] [Abstract][Full Text] [Related]
25. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
[TBL] [Abstract][Full Text] [Related]
26. Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer.
Kim DH; Kim JS; Park JH; Lee SK; Ji YI; Kwon YM; Shim YM; Han J; Park J
Cancer Res; 2003 Oct; 63(19):6206-11. PubMed ID: 14559805
[TBL] [Abstract][Full Text] [Related]
27. Blocking oncogenic Ras signaling for cancer therapy.
Adjei AA
J Natl Cancer Inst; 2001 Jul; 93(14):1062-74. PubMed ID: 11459867
[TBL] [Abstract][Full Text] [Related]
28. K-Ras and its inhibitors towards personalized cancer treatment: Pharmacological and structural perspectives.
Asati V; Mahapatra DK; Bharti SK
Eur J Med Chem; 2017 Jan; 125():299-314. PubMed ID: 27688185
[TBL] [Abstract][Full Text] [Related]
29. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer.
Castagnola P; Giaretti W
Biochim Biophys Acta; 2005 Nov; 1756(2):115-25. PubMed ID: 16112461
[TBL] [Abstract][Full Text] [Related]
30. [Research advances of K-ras mutation in the prognosis and targeted therapy of gastric cancer].
Huang Y; Wei J; Liu BR
Zhonghua Zhong Liu Za Zhi; 2016 Feb; 38(2):81-5. PubMed ID: 26899324
[TBL] [Abstract][Full Text] [Related]
31. K-ras as a target for cancer therapy.
Friday BB; Adjei AA
Biochim Biophys Acta; 2005 Nov; 1756(2):127-44. PubMed ID: 16139957
[TBL] [Abstract][Full Text] [Related]
32. Loss of RhoA Exacerbates, Rather Than Dampens, Oncogenic K-Ras Induced Lung Adenoma Formation in Mice.
Zandvakili I; Davis AK; Hu G; Zheng Y
PLoS One; 2015; 10(6):e0127923. PubMed ID: 26030593
[TBL] [Abstract][Full Text] [Related]
33. RASpecting the oncogene: New pathways to therapeutic advances.
Stout MC; Campbell PM
Biochem Pharmacol; 2018 Dec; 158():217-228. PubMed ID: 30352234
[TBL] [Abstract][Full Text] [Related]
34. Oncogenic RAS: From Its Activation to Its Direct Targeting.
Zaravinos A
Crit Rev Oncog; 2017; 22(3-4):283-301. PubMed ID: 29604905
[TBL] [Abstract][Full Text] [Related]
35. K-Ras protein as a drug target.
McCormick F
J Mol Med (Berl); 2016 Mar; 94(3):253-8. PubMed ID: 26960760
[TBL] [Abstract][Full Text] [Related]
36. Ras signaling pathway proteins as therapeutic targets.
Adjei AA
Curr Pharm Des; 2001 Nov; 7(16):1581-94. PubMed ID: 11562300
[TBL] [Abstract][Full Text] [Related]
37. Synthetic lethal genetic screens in Ras mutant cancers.
Yu B; Luo J
Enzymes; 2013; 34 Pt. B():201-19. PubMed ID: 25034106
[TBL] [Abstract][Full Text] [Related]
38. [Growth factor and signal transduction in lung cancer cell].
Yoshida T; Kunito H; Saijo N
Nihon Rinsho; 2000 May; 58(5):1023-30. PubMed ID: 10824543
[TBL] [Abstract][Full Text] [Related]
39. Non-redundancy within the RAS oncogene family: insights into mutational disparities in cancer.
Lau KS; Haigis KM
Mol Cells; 2009 Oct; 28(4):315-20. PubMed ID: 19812895
[TBL] [Abstract][Full Text] [Related]
40. The Myc and Ras Partnership in Cancer: Indistinguishable Alliance or Contextual Relationship?
Mahauad-Fernandez WD; Felsher DW
Cancer Res; 2020 Sep; 80(18):3799-3802. PubMed ID: 32732221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
